Chandra SA, Stokes AH, Hailey R, Merrill CL, Melich DH, DeSmet K, Furst SM, Peterson RA, Mellon-Kusibab K, Adler RR. Dermal Toxicity Studies: Factors Impacting Study Interpretation and Outcome. Toxicol Pathol. 2014 Nov 10. Chandra SA, Peterson RA, Melich D, Merrill CM, Bailey D, Mellon-Kusibab K, Adler R. Dermal Irritation of Petrolatum in Rabbits but not in Mice, Rats or Minipigs. J Appl Toxicol. 2014 Aug;34(8):857-61. Brown HR, Mellon-Kusibab K, Bertram R, Tillman T, Arrington-Brown L, Jordan H, Gates L, Miller RT.Brief Communication: Intraperitoneal Galactosamine Misdosing as a Possible Interpretation for Responder/Nonresponder Phenotypes. Toxicol Pathol. 2014;42(3):622-625. Tippin TK, Hamilton G, Moore L, Beaudet EJ, Jolley S, Brodie TA, Andrews RC, Becherer JD, McDougald DL, Gaul MD, Hoivik DJ, Mellon-Kusibab K, Lehmann J, Kliewer S, Novick S, Laethem R, Zhao Z, LeCluyse EL. CYP3A Induction by N-Hydroxyformamide Tumor Necrosis Factor- Converting Enzyme/Matrix Metalloproteinase Inhibitors: Use of a Pregnane X Receptor Activation Assay and Primary Hepatocyte Culture for Assessing Induction Potential in Humans. Drug Metabolism and Disposition 31:870-877. PRESENTATIONS Mellon-Kusibab, K. Drug-Induced Liver Fibrosis - Testing Nevirapine in a Viral-Like Liver Setting. A Time-Course Experiment in Brown Norway Rats. PTS DISCovery Science Forum, GlaxoSmithKline, November 21, 2014. Mellon-Kusibab KA, Perkins DG, Tyler R, Brouwer KR, Serabjit-Singh CJ, and Boehlert C. One-Month Oral Gavage Toxicity Study with GF120918 in Beagle Dogs. Abstracts for the 21st Annual Meeting of the American College of Toxicology November 12-15, 2000 San Diego, California, USA. International Journal of Toxicology. November 2000 19: 1-37 Mellon-Kusibab K, Natvig B, Hoivik D, McKinney D, and Dillberger J. Labrafil: Effect of Oral Administration to Han Wistar Rats for a Period of 6 Months. Poster Session, 1998 Annual Group Development Operations US Symposium, Girolami Research Center, Glaxo Wellcome Inc. Mellon-Kusibab K, Hoivik D, Allen D, Brodie T, Tippin T. Screening New Compounds for Toxicological Effects during the Drug Discovery Process. Poster Session, Discovery Day, Glaxo Wellcome Inc., September 9, 1998. Brouwer, KR, Perkins, D, Kerr B, Roberts, PA, Mellon-Kusibab, K, and Wissel, P. Pre-Clinical Guidance for Phase I Trials with MDR Modulators and Chemotherapy: The Effect of GF120918 (GW918) on the Pharmacokinetics and Pharmacodynamics of Doxorubicin. Proceedings of the American Association for Cancer Research Annual Meeting 37 (0). 1996. 375. Boehlert C, Mellon-Kusibab KA, Tyler R, and Serabjit-Singh CJ. Effect of Inducers on Hepatic Tissue from Male and Female Beagle Dogs. Poster Session, Society of Toxicology 34th Annual Meeting, March 1995.